정신분열증 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Persistence Market Research recently unveiled an in-depth report on the global Schizophrenia Treatment Market, analyzing key market dynamics, including drivers, trends, opportunities, and challenges. This comprehensive research provides exclusive data and projections for the schizophrenia treatment market's growth trajectory from 2024 to 2031.

Key Insights:

• Schizophrenia Treatment Market Size (2024E): US$ 8.4 Billion
• Projected Market Value (2031F): US$ 12.0 Billion
• Global Market Growth Rate (CAGR 2024 to 2031): 5.3%

Schizophrenia Treatment Market Overview:

Schizophrenia is a chronic and severe mental disorder that affects how individuals think, feel, and behave, often leading to significant challenges in daily life. Treatment typically involves antipsychotic medications, psychotherapy, and supportive care. The market for schizophrenia treatment includes a wide range of products, such as oral and injectable antipsychotics, cognitive therapies, and supportive services. Key drivers of market growth include the increasing prevalence of schizophrenia, advancements in drug development, and growing awareness surrounding mental health.

Market Growth Drivers:

The global schizophrenia treatment market is experiencing growth due to several factors, including an increasing incidence of schizophrenia diagnoses, especially in urbanized and high-stress societies. The advancement of novel antipsychotic drugs, which offer fewer side effects compared to older treatments, is driving demand for more effective treatment options. Additionally, the growing focus on mental health awareness and destigmatization of psychiatric disorders is encouraging more patients to seek treatment. Increased research funding and partnerships between pharmaceutical companies and mental health organizations are also contributing to market growth.

Market Restraints:

Despite strong growth prospects, the schizophrenia treatment market faces several challenges. High treatment costs, especially for newer biologic and injectable antipsychotics, can limit access to care in low- and middle-income regions. Additionally, patients' non-compliance with prescribed treatment regimens due to side effects or misconceptions about antipsychotic medications can slow treatment efficacy. The long and complex drug approval processes in many regions can also hinder the rapid availability of new treatment options. Moreover, the stigma surrounding mental illness may prevent some individuals from seeking the necessary care.

Market Opportunities:

The schizophrenia treatment market offers significant opportunities, driven by ongoing advancements in drug formulations, including long-acting injectable antipsychotics that improve patient adherence. The rise in mental health awareness presents an opportunity for broader market acceptance and better early diagnosis, which is crucial for effective treatment. The increasing acceptance and use of telemedicine and online therapy for mental health conditions also open new avenues for patient care. Additionally, expansion into emerging markets, where mental health disorders are gaining more recognition, presents substantial growth potential.

Key Questions Addressed:

• What are the primary factors driving the global growth of the schizophrenia treatment market?
• Which treatment types and drug formulations are witnessing the highest adoption in the schizophrenia treatment market?
• How are advancements in treatment technologies and drug delivery systems impacting the competitive landscape of the schizophrenia treatment market?
• Who are the leading players in the schizophrenia treatment market, and what strategies are they employing to maintain leadership?
• What are the emerging trends and future prospects for the global schizophrenia treatment market?

Competitive Intelligence & Strategic Insights:

Key players in the global schizophrenia treatment market, including Johnson & Johnson, Otsuka Pharmaceutical, and Roche, are focused on product innovation, strategic partnerships, and expanding their treatment portfolios to strengthen their market presence. These companies invest heavily in research and development to introduce next-generation antipsychotics with improved efficacy and reduced side effects. Collaborations with healthcare providers, mental health organizations, and digital health platforms are key strategies to enhance market reach and improve patient outcomes. Additionally, educational campaigns to reduce the stigma around mental health conditions and promote early treatment are essential to increasing market adoption and improving the lives of individuals living with schizophrenia.

Key Companies Profiled:

• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Otsuka Holdings Co., Ltd
• AstraZeneca
• Sumitomo Dainippon Pharma Co., Ltd.
• Eli Lilly and Company
• Alkermes
• Vanda Pharmaceuticals
• ALLERGAN
• Pfizer Inc.

Market Segmentation

By Product Type

• Atypical Antipsychotics
• Phenothiazine Antipsychotics
• Thioxanthenes
• Miscellaneous Antipsychotic Agents

By Distribution Channel

• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• E-Commerce

By Region

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific Excluding Japan (APEJ)
• Japan
• Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis
• 1.3. PMR Analysis and Recommendations
• 1.4. Wheel of Fortune

2. Market Introduction

• 2.1. Market Definition
• 2.2. Market Taxonomy
• 2.3. Schizophrenia Treatment Market Overview

3. Market View Point

• 3.1. Macro factors
• 3.2. Drivers
• 3.3. Restraints
• 3.4. Trends
• 3.5. Pipeline Analysis
• 3.6. Opportunities
• 3.7. Key Regulations

4. North America Schizophrenia Treatment Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 4.1. Introduction
• 4.2. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2023
  • 4.2.1. U.S.
  • 4.2.2. Canada
• 4.3. Market Size (US$ Bn) Forecast By Country, 2024 - 2031
  • 4.3.1. U.S.
  • 4.3.2. Canada
• 4.4. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 - 2023
  • 4.4.1. Atypical Antipsychotics
  • 4.4.2. Phenothiazine Antipsychotics
  • 4.4.3. Thioxanthenes
  • 4.4.4. Miscellaneous Antipsychotics Agents
• 4.5. Market Size (US$ Bn) Forecast By Product Type, 2024 - 2031
  • 4.5.1. Atypical Antipsychotics
  • 4.5.2. Phenothiazine Antipsychotics
  • 4.5.3. Thioxanthenes
  • 4.5.4. Miscellaneous Antipsychotics Agents
• 4.6. Historical Market Size (US$ Bn) Analysis By End User, 2019 - 2023
  • 4.6.1. Hospital Pharmacies
  • 4.6.2. Drug Stores
  • 4.6.3. Retail Pharmacies
  • 4.6.4. E-Commerce
• 4.7. Market Size (US$ Bn) Forecast By End User, 2024 - 2031
  • 4.7.1. Hospital Pharmacies
  • 4.7.2. Drug Stores
  • 4.7.3. Retail Pharmacies
  • 4.7.4. E-Commerce
• 4.8. Market Attractiveness Analysis
  • 4.8.1. By Country
  • 4.8.2. By Product Type
  • 4.8.3. By End User
• 4.9. Key Representative Market Participants
• 4.10. Key Participants Market Presence (Intensity Map)

5. Latin America Schizophrenia Treatment Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 5.1. Introduction
• 5.2. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2023
  • 5.2.1. Brazil
  • 5.2.2. Mexico
  • 5.2.3. Rest of Latin America
• 5.3. Market Size (US$ Bn) Forecast By Country, 2024 - 2031
  • 5.3.1. Brazil
  • 5.3.2. Mexico
  • 5.3.3. Rest of Latin America
• 5.4. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 - 2023
  • 5.4.1. Atypical Antipsychotics
  • 5.4.2. Phenothiazine Antipsychotics
  • 5.4.3. Thioxanthenes
  • 5.4.4. Miscellaneous Antipsychotics Agents
• 5.5. Market Size (US$ Bn) Forecast By Product Type, 2024 - 2031
  • 5.5.1. Atypical Antipsychotics
  • 5.5.2. Phenothiazine Antipsychotics
  • 5.5.3. Thioxanthenes
  • 5.5.4. Miscellaneous Antipsychotics Agents
• 5.6. Historical Market Size (US$ Bn) Analysis By End User, 2019 - 2023
  • 5.6.1. Hospital Pharmacies
  • 5.6.2. Drug Stores
  • 5.6.3. Retail Pharmacies
  • 5.6.4. E-Commerce
• 5.7. Market Size (US$ Bn) Forecast By End User, 2024 - 2031
  • 5.7.1. Hospital Pharmacies
  • 5.7.2. Drug Stores
  • 5.7.3. Retail Pharmacies
  • 5.7.4. E-Commerce
• 5.8. Market Attractiveness Analysis
  • 5.8.1. By Country
  • 5.8.2. By Product Type
  • 5.8.3. By End User
• 5.9. Key Representative Market Participants
• 5.10. Key Participants Market Presence (Intensity Map)

6. Western Europe Schizophrenia Treatment Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 6.1. Introduction
• 6.2. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2023
  • 6.2.1. Germany
  • 6.2.2. U.K
  • 6.2.3. France
  • 6.2.4. Spain
  • 6.2.5. Italy
  • 6.2.6. Nordic Countries
  • 6.2.7. Rest of Western Europe
• 6.3. Market Size (US$ Bn) Forecast By Country, 2024 - 2031
  • 6.3.1. Germany
  • 6.3.2. U.K
  • 6.3.3. France
  • 6.3.4. Spain
  • 6.3.5. Italy
  • 6.3.6. Nordic Countries
  • 6.3.7. Rest of Western Europe
• 6.4. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 - 2023
  • 6.4.1. Atypical Antipsychotics
  • 6.4.2. Phenothiazine Antipsychotics
  • 6.4.3. Thioxanthenes
  • 6.4.4. Miscellaneous Antipsychotics Agents
• 6.5. Market Size (US$ Bn) Forecast By Product Type, 2024 - 2031
  • 6.5.1. Atypical Antipsychotics
  • 6.5.2. Phenothiazine Antipsychotics
  • 6.5.3. Thioxanthenes
  • 6.5.4. Miscellaneous Antipsychotics Agents
• 6.6. Historical Market Size (US$ Bn) Analysis By End User, 2019 - 2023
  • 6.6.1. Hospital Pharmacies
  • 6.6.2. Drug Stores
  • 6.6.3. Retail Pharmacies
  • 6.6.4. E-Commerce
• 6.7. Market Size (US$ Bn) Forecast By End User, 2024 - 2031
  • 6.7.1. Hospital Pharmacies
  • 6.7.2. Drug Stores
  • 6.7.3. Retail Pharmacies
  • 6.7.4. E-Commerce
• 6.8. Market Attractiveness Analysis
  • 6.8.1. By Country
  • 6.8.2. By Product Type
  • 6.8.3. By End User
• 6.9. Key Representative Market Participants
• 6.10. Key Participants Market Presence (Intensity Map)

7. Eastern Europe Schizophrenia Treatment Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 7.1. Introduction
• 7.2. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2023
  • 7.2.1. Russia
  • 7.2.2. Poland
  • 7.2.3. Rest of Eastern Europe
• 7.3. Market Size (US$ Bn) Forecast By Country, 2024 - 2031
  • 7.3.1. Russia
  • 7.3.2. Poland
  • 7.3.3. Rest of Eastern Europe
• 7.4. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 - 2023
  • 7.4.1. Atypical Antipsychotics
  • 7.4.2. Phenothiazine Antipsychotics
  • 7.4.3. Thioxanthenes
  • 7.4.4. Miscellaneous Antipsychotics Agents
• 7.5. Market Size (US$ Bn) Forecast By Product Type, 2024 - 2031
  • 7.5.1. Atypical Antipsychotics
  • 7.5.2. Phenothiazine Antipsychotics
  • 7.5.3. Thioxanthenes
  • 7.5.4. Miscellaneous Antipsychotics Agents
• 7.6. Historical Market Size (US$ Bn) Analysis By End User, 2019 - 2023
  • 7.6.1. Hospital Pharmacies
  • 7.6.2. Drug Stores
  • 7.6.3. Retail Pharmacies
  • 7.6.4. E-Commerce
• 7.7. Market Size (US$ Bn) Forecast By End User, 2024 - 2031
  • 7.7.1. Hospital Pharmacies
  • 7.7.2. Drug Stores
  • 7.7.3. Retail Pharmacies
  • 7.7.4. E-Commerce
• 7.8. Market Attractiveness Analysis
  • 7.8.1. By Country
  • 7.8.2. By Product Type
  • 7.8.3. By End User
• 7.9. Key Representative Market Participants
• 7.10. Key Participants Market Presence (Intensity Map)

8. APEJ Schizophrenia Treatment Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 8.1. Introduction
• 8.2. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2023
  • 8.2.1. China
  • 8.2.2. India
  • 8.2.3. Australia & NZ
  • 8.2.4. ASEAN
  • 8.2.5. Rest of APEJ
• 8.3. Market Size (US$ Bn) Forecast By Country, 2024 - 2031
  • 8.3.1. China
  • 8.3.2. India
  • 8.3.3. Australia & NZ
  • 8.3.4. ASEAN
  • 8.3.5. Rest of APEJ
• 8.4. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 - 2023
  • 8.4.1. Atypical Antipsychotics
  • 8.4.2. Phenothiazine Antipsychotics
  • 8.4.3. Thioxanthenes
  • 8.4.4. Miscellaneous Antipsychotics Agents
• 8.5. Market Size (US$ Bn) Forecast By Product Type, 2024 - 2031
  • 8.5.1. Atypical Antipsychotics
  • 8.5.2. Phenothiazine Antipsychotics
  • 8.5.3. Thioxanthenes
  • 8.5.4. Miscellaneous Antipsychotics Agents
• 8.6. Historical Market Size (US$ Bn) Analysis By End User, 2019 - 2023
  • 8.6.1. Hospital Pharmacies
  • 8.6.2. Drug Stores
  • 8.6.3. Retail Pharmacies
  • 8.6.4. E-Commerce
• 8.7. Market Size (US$ Bn) Forecast By End User, 2024 - 2031
  • 8.7.1. Hospital Pharmacies
  • 8.7.2. Drug Stores
  • 8.7.3. Retail Pharmacies
  • 8.7.4. E-Commerce
• 8.8. Market Attractiveness Analysis
  • 8.8.1. By Country
  • 8.8.2. By Product Type
  • 8.8.3. By End User
• 8.9. Key Representative Market Participants
• 8.10. Key Participants Market Presence (Intensity Map)

9. Japan Schizophrenia Treatment Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 9.1. Introduction
• 9.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 - 2023
  • 9.2.1. Atypical Antipsychotics
  • 9.2.2. Phenothiazine Antipsychotics
  • 9.2.3. Thioxanthenes
  • 9.2.4. Miscellaneous Antipsychotics Agents
• 9.3. Market Size (US$ Bn) Forecast By Product Type, 2024 - 2031
  • 9.3.1. Atypical Antipsychotics
  • 9.3.2. Phenothiazine Antipsychotics
  • 9.3.3. Thioxanthenes
  • 9.3.4. Miscellaneous Antipsychotics Agents
• 9.4. Historical Market Size (US$ Bn) Analysis By End User, 2019 - 2023
  • 9.4.1. Hospital Pharmacies
  • 9.4.2. Drug Stores
  • 9.4.3. Retail Pharmacies
  • 9.4.4. E-Commerce
• 9.5. Market Size (US$ Bn) Forecast By End User, 2024 - 2031
  • 9.5.1. Hospital Pharmacies
  • 9.5.2. Drug Stores
  • 9.5.3. Retail Pharmacies
  • 9.5.4. E-Commerce
• 9.6. Market Attractiveness Analysis
  • 9.6.1. By Product Type
  • 9.6.2. By End User
• 9.7. Key Representative Market Participants
• 9.8. Key Participants Market Presence (Intensity Map)

10. MEA Schizophrenia Treatment Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 10.1. Introduction
• 10.2. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2023
  • 10.2.1. GCC Countries
  • 10.2.2. South Africa
  • 10.2.3. Rest of MEA
• 10.3. Market Size (US$ Bn) Forecast By Country, , 2024 - 2031
  • 10.3.1. GCC Countries
  • 10.3.2. South Africa
  • 10.3.3. Rest of MEA
• 10.4. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 - 2023
  • 10.4.1. Atypical Antipsychotics
  • 10.4.2. Phenothiazine Antipsychotics
  • 10.4.3. Thioxanthenes
  • 10.4.4. Miscellaneous Antipsychotics Agents
• 10.5. Market Size (US$ Bn) Forecast By Product Type, 2024 - 2031
  • 10.5.1. Atypical Antipsychotics
  • 10.5.2. Phenothiazine Antipsychotics
  • 10.5.3. Thioxanthenes
  • 10.5.4. Miscellaneous Antipsychotics Agents
• 10.6. Historical Market Size (US$ Bn) Analysis By End User, 2019 - 2023
  • 10.6.1. Hospital Pharmacies
  • 10.6.2. Drug Stores
  • 10.6.3. Retail Pharmacies
  • 10.6.4. E-Commerce
• 10.7. Market Size (US$ Bn) Forecast By End User, 2024 - 2031
  • 10.7.1. Hospital Pharmacies
  • 10.7.2. Drug Stores
  • 10.7.3. Retail Pharmacies
  • 10.7.4. E-Commerce
• 10.8. Market Attractiveness Analysis
  • 10.8.1. By Country
  • 10.8.2. By Product Type
  • 10.8.3. By End User
• 10.9. Key Representative Market Participants
• 10.10. Key Participants Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

• 13.1. Competition Dashboard
• 13.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.2.1. Johnson & Johnson Services, Inc.
  • 13.2.2. Bristol-Myers Squibb Company
  • 13.2.3. Otsuka Holdings Co., Ltd
  • 13.2.4. AstraZeneca
  • 13.2.5. Sumitomo Dainippon Pharma Co., Ltd.
  • 13.2.6. Eli Lilly and Company
  • 13.2.7. Alkermes
  • 13.2.8. Vanda Pharmaceuticals
  • 13.2.9. ALLERGAN
  • 13.2.10. Pfizer Inc.

14. Global Schizophrenia Treatment Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Region

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Analysis By Region, 2019 - 2023
  • 14.2.1. North America
  • 14.2.2. Latin America
  • 14.2.3. Western Europe
  • 14.2.4. Eastern Europe
  • 14.2.5. APEJ
  • 14.2.6. Japan
  • 14.2.7. MEA
• 14.3. Market Size (US$ Bn) Forecast By Region, 2024 - 2031
  • 14.3.1. North America
  • 14.3.2. Latin America
  • 14.3.3. Western Europe
  • 14.3.4. Eastern Europe
  • 14.3.5. APEJ
  • 14.3.6. Japan
  • 14.3.7. MEA
• 14.4. Market Attractiveness Analysis By Region

15. Global Schizophrenia Treatment Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Product Type

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2019 - 2023
  • 15.2.1. Atypical Antipsychotics
  • 15.2.2. Phenothiazine Antipsychotics
  • 15.2.3. Thioxanthenes
  • 15.2.4. Miscellaneous Antipsychotics Agents
• 15.3. Market Size (US$ Bn) Forecast By Product Type, 2024 - 2031
  • 15.3.1. Atypical Antipsychotics
  • 15.3.2. Phenothiazine Antipsychotics
  • 15.3.3. Thioxanthenes
  • 15.3.4. Miscellaneous Antipsychotics Agents
• 15.4. Market Attractiveness Analysis By Product Type

16. Global Schizophrenia Treatment Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By End User

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Analysis By End User, 2019 - 2023
  • 16.2.1. Hospital Pharmacies
  • 16.2.2. Drug Stores
  • 16.2.3. Retail Pharmacies
  • 16.2.4. E-Commerce
• 16.3. Market Size (US$ Bn) Forecast By End User, 2024 - 2031
  • 16.3.1. Hospital Pharmacies
  • 16.3.2. Drug Stores
  • 16.3.3. Retail Pharmacies
  • 16.3.4. E-Commerce
• 16.4. Market Attractiveness Analysis By End User

17. Global Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 17.1. Market Size and Y-o-Y Growth
• 17.2. Absolute $ Opportunity

18. Research Methodology